About OPTIMA

! For patients who are looking for information about COVID-19 and OPTIMA, click here.
    ! For recruiting teams who are looking for information about COVID-19 and OPTIMA, click here.

      Welcome to OPTIMA, a patient driven clinical study for people with hormone sensitive early breast cancer. OPTIMA aims to improve the way we make decisions about whom we offer chemotherapy to following surgery.

      Professor Rob Stein – Chief investigator